quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:51:15·885d
SECFiling
Acer Therapeutics Inc. logo

SEC Form 10-Q filed by Acer Therapeutics Inc.

ACER· Acer Therapeutics Inc.
Health Care
Original source

Companies

  • ACER
    Acer Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Feb 2UpdateEF Hutton$9.00

Related

  • NEWS765d
    Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
  • SEC875d
    SEC Form 15-12G filed by Acer Therapeutics Inc.
  • SEC879d
    SEC Form EFFECT filed by Acer Therapeutics Inc.
  • SEC879d
    SEC Form EFFECT filed by Acer Therapeutics Inc.
  • INSIDER885d
    Aselage Steve returned 483,741 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER885d
    Dunn John Michael returned 27,380 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER885d
    Joseph Donald returned 14,285 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER885d
    Schelling Chris returned 2,712,529 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022